Literature DB >> 22313379

Pathology of demyelinating diseases.

Bogdan F Gh Popescu1, Claudia F Lucchinetti.   

Abstract

There has been significant progress in our understanding of the pathology and pathogenesis of central nervous system inflammatory demyelinating diseases. Neuropathological studies have provided fundamental new insights into the pathogenesis of these disorders and have led to major advances in our understanding of multiple sclerosis (MS) heterogeneity, the substrate of irreversible progressive disability in MS, the relationship between inflammation and neurodegeneration in MS, the neuroimaging correlates of MS lesions, and the pathogenesis of other central nervous system inflammatory disorders, including neuromyelitis optica, acute disseminated encephalomyelitis, and Balo's concentric sclerosis. Herein, we review the pathological features of these central nervous system inflammatory demyelinating disorders and discuss neuropathological studies that have yielded novel insights into potential mechanisms involved in the formation of the demyelinated lesion.

Entities:  

Mesh:

Year:  2012        PMID: 22313379     DOI: 10.1146/annurev-pathol-011811-132443

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  112 in total

Review 1.  Mechanisms regulating regional localization of inflammation during CNS autoimmunity.

Authors:  Emily Pierson; Sarah B Simmons; Luca Castelli; Joan M Goverman
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 2.  Microenvironmental regulation of oligodendrocyte replacement and remyelination in spinal cord injury.

Authors:  Arsalan Alizadeh; Soheila Karimi-Abdolrezaee
Journal:  J Physiol       Date:  2016-03-29       Impact factor: 5.182

3.  Autoantibody depletion ameliorates disease in murine experimental autoimmune encephalomyelitis.

Authors:  Dilip K Challa; Uta Bussmeyer; Tarique Khan; Héctor P Montoyo; Pankaj Bansal; Raimund J Ober; E Sally Ward
Journal:  MAbs       Date:  2013-06-19       Impact factor: 5.857

4.  Immunomodulatory function of Treg-derived exosomes is impaired in patients with relapsing-remitting multiple sclerosis.

Authors:  Maryam Azimi; Mojdeh Ghabaee; Abdorreza Naser Moghadasi; Farshid Noorbakhsh; Maryam Izad
Journal:  Immunol Res       Date:  2018-08       Impact factor: 2.829

5.  Spectral characteristics of semisolid protons in human brain white matter at 7 T.

Authors:  Xu Jiang; Peter van Gelderen; Jeff H Duyn
Journal:  Magn Reson Med       Date:  2017-02-02       Impact factor: 4.668

6.  Clinical and MRI phenotype of children with MOG antibodies.

Authors:  Cristina Fernandez-Carbonell; David Vargas-Lowy; Alexander Musallam; Brian Healy; Katherine McLaughlin; Kai W Wucherpfennig; Tanuja Chitnis
Journal:  Mult Scler       Date:  2015-06-03       Impact factor: 6.312

7.  [Inflammatory diseases of the central nervous system].

Authors:  Armin Bachhuber
Journal:  Radiologe       Date:  2021-06-08       Impact factor: 0.635

8.  Optic Neuritis: A Model for the Immuno-pathogenesis of Central Nervous System Inflammatory Demyelinating Diseases.

Authors:  Gregory F Wu; Chelsea R Parker Harp; Kenneth S Shindler
Journal:  Curr Immunol Rev       Date:  2015

9.  Isolation of Astrocytes Displaying Myofibroblast Properties and Present in Multiple Sclerosis Lesions.

Authors:  Nicolas Vedrenne; Vincent Sarrazy; Laurence Richard; Nelly Bordeau; Serge Battu; Fabrice Billet; Alexis Desmoulière
Journal:  Neurochem Res       Date:  2017-04-22       Impact factor: 3.996

Review 10.  Reactive gliosis and the multicellular response to CNS damage and disease.

Authors:  Joshua E Burda; Michael V Sofroniew
Journal:  Neuron       Date:  2014-01-22       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.